Adalvo Limited Lek Pharmaceuticals d.d. Pharmadox Healthcare Ltd. Qualimetrix S.A.

The medicine is used for the treatment of idiopathic pulmonary fibrosis (IPF) in adults, other chronic fibrosing interstitial lung diseases (ILD) in adults, as well as in children and adolescents (from 6 years of age) in the case of clinically significant, progressive lung diseases and systemic sclerosis-associated interstitial lung disease.

Dosage form: capsules, soft gelatin

ATC: L01EX09

The medicine is used in adults for the treatment of idiopathic pulmonary fibrosis (IPF) and other chronic lung diseases with interstitial lung disease (ILD). It is also used in children and adolescents (from 6 years of age) in the case of clinically significant, progressive lung diseases, and in people (adults and children from 6 years of age) with systemic sclerosis-associated interstitial lung disease.

Dosage form: capsules, soft gelatin

ATC: L01EX09